|本期目录/Table of Contents|

[1]王莲,范华霞,罗芳,等.冠状动脉内旋磨术术中并发症及术后12个月内主要不良心血管事件的影响因素分析[J].国际心血管病杂志,2024,04:251-255.
　WANG Lian,FAN Huaxia,LUO Fang,et al.Potential factors influencing complications during rotational atherectomy and major adverse cardiovascular events within 12 months[J].International Journal of Cardiovascular Disease,2024,04:251-255.
点击复制

冠状动脉内旋磨术术中并发症及术后12个月内主要不良心血管事件的影响因素分析(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2024年04期
页码:
251-255
栏目:
临床研究
出版日期:
2024-07-31

文章信息/Info

Title:
Potential factors influencing complications during rotational atherectomy and major adverse cardiovascular events within 12 months
作者:
王莲; 范华霞; 罗芳; 陈智玲; 周杨; 梁俐
作者单位：644099 宜宾市第一人民医院心内科（王莲，范华霞，罗芳，陈智玲）；644099 宜宾市第三人民医院心内科（周杨），消化内科（梁俐）
Author(s):
WANG Lian1;  FAN Huaxia1;  LUO Fang1;  CHEN Zhiling1;  ZHOU Yang2;  LIANG Li3
1. Department of Cardiology, The First People's Hospital of Yibin, Yibin? 644099; 2. Department of Cardiology, The Third People's Hospital of Yibin, Yibin? 644099;3. Department of Gastroenterology, The Third People's Hospital of Yibin, Yibin? 644099, Chin
关键词:
冠状动脉内旋磨术; 经皮冠状动脉介入治疗; 并发症; 主要不良心血管事件
Keywords:
Rotational atherectomy;  Percutaneous coronary intervention;  Complication; Major adverse cardiovascular events
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2024.04.015
文献标识码:
-
摘要:
目的：探讨冠状动脉内旋磨术（RA）术中并发症及术后12个月内主要不良心血管事件（MACE）的影响因素。方法：回顾性分析2017年1月至2020年12月宜宾市第一人民医院和宜宾市第三人民医院收治的316例行RA的患者，收集临床病例资料，采用多因素logistic回归分析术中并发症和术后12个月内MACE的影响因素。结果：RA术中并发症和术后12个月内MACE的发生率分别为15.8%和22.9%，多因素分析显示心力衰竭史、SYNTAX评分及旋磨头血管内径比是RA术中并发症的影响因素（P均＜0.05）；RA术后
Abstract:
Objective: To explore the possible factors related to complications during rotational atherectomy (RA) and major adverse cardiac events (MACE) within 12 months after the procedure.? Methods: Clinical data of 316 patients who underwent RA at The First Peop

参考文献/References

[1] Kato T, Fujino M, Takagi K, et al. The rotational atherectomy with a guide extension catheter for calcified and tortuous lesions in left anterior descending artery: a case report[J]. BMC Cardiovasc Disord, 2021, 21(1):360.
[2] Lee SN, Her SH, Jang WY, et al. Impact of chronic total occlusion lesions on clinical outcomes in patients receiving rotational atherectomy: results from the ROCK registry[J]. Heart Vessels, 2021, 36(11):1617-1625.
[3] Barbieri L, Tumminello G, Lucreziotti S, et al. Safety and efficacy of rotational atherectomy in heavily calcified lesions involving coronary aneurysms[J]. Future Cardiol, 2021, 17(7):1199-1205.
[4] 刘耀琨, 郑博, 陈楚云, 等. 中国县域医院心血管专科冠状动脉复杂病变介入治疗能力现状—基于2021年304家县级医院的调研[J]. 中国介入心脏病学杂志, 2022, 30(8):596-600.
[5] Sharma SK, Tomey MI, Teirstein PS, et al. North American expert review of rotational atherectomy[J]. Circ Cardiovasc Interv, 2019, 12(5):e007448.
[6] W?odarczak A, Rola P, Barycki M, et al. Rota-lithotripsy-a novel bail-out strategy for calcified coronary lesions in acute coronary syndrome. The first-in-man experience[J]. J Clin Med, 2021, 10(9):1872.
[7] Gurm HS, Sukul D. Drilling down to quality: rotational atherectomy, operator volume, and PCI outcomes[J]. JACC Cardiovasc Interv, 2021, 14(13):1431-1433.
[8] Sakakura K, Ito Y, Shibata Y, et al. Correction to: clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics[J]. Cardiovasc Interv Ther, 2021, 36(1):19.
[9] 张慧平, 赵迎, 李辉, 等. 冠状动脉旋磨术围术期并发症分析[J]. 中国介入心脏病学杂志, 2018, 26(1):36-40.
[10] 宋倩, 陈韬, 郭军. 冠状动脉内旋磨术缺血并发症影响因素分析[J]. 临床军医杂志, 2020, 48(5):609-610, 612.
[11] Yoon YH, Ahn JM, Kang DY, et al. Impact of SYNTAX score on 10-year outcomes after revascularization for left main coronary artery disease[J]. JACC Cardiovasc Interv, 2020, 13(3):361-371.
[12] Mankerious N, Hemetsberger R, Traboulsi H, et al. Predictors of in-hospital adverse outcomes after rotational atherectomy: impact of the target vessel SYNTAX score[J]. Cardiovasc Revasc Med,2020, 21(6):754-759.
[13] 王伟民, 霍勇, 葛均波, 等. 冠状动脉钙化病变诊治中国专家共识（2021版）[J]. 中国介入心脏病学杂志, 2021, 29(5):251-259.
[14] Safarian H, Alidoosti M, Shafiee A, et al. The SYNTAX score can predict major adverse cardiac events following percutaneous coronary intervention[J]. Heart Views, 2014, 15(4):99-105.
[15] 韩风杰, 郑海军, 郑献召, 等. 血管内超声指导下的旋磨术联合切割球囊预处理冠状动脉重度钙化病变：120例前瞻性随机对照试验[J]. 南方医科大学学报, 2021, 41(7):1044-1049.
[16] Redfors B, Chen S, Ben-Yehuda O, et al. Association between hypertension, platelet reactivity, and the risk of adverse events after percutaneous coronary intervention (from the ADAPT-DES study)[J]. Am J Cardiol, 2019, 124(9):1380-1388.
[17] Pereira GTR, Dallan LAP, Vergara-Martel A, et al. Treatment of in-stent restenosis using excimer laser coronary atherectomy and bioresorbable vascular scaffold guided by optical coherence tomography[J]. Cardiovasc Revasc Med, 2021, 22:44-49.
[18] Heffron SP, Ruuth MK, Xia YH, et al. Low-density lipoprotein aggregation predicts adverse cardiovascular events in peripheral artery disease[J]. Atherosclerosis, 2021, 316:53-57.
[19] Lao Y, Feng L, Yuan Y, et al. Prognostic value of hemoglobin A1c levels in postmenopausal diabetic patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome[J]. Med Sci Monit, 2018, 24:9399-9405.
[20] Baber U, Azzalini L, Masoomi R, et al. Hemoglobin A1c and cardiovascular outcomes following percutaneous coronary intervention: insights from a large single-center registry[J]. JACC Cardiovasc Interv, 2021, 14(4):388-397.

备注/Memo

备注/Memo:
基金项目：四川省卫健委科研项目（18PJ549）
通信作者：梁俐， E-mail：huaxi19795@126.com
更新日期/Last Update: 2024-07-31